Cell Therapy, Immunotherapy & Vaccines
At JPT Peptide Technologies, we specialize in cutting-edge peptide-based solutions for cell therapy, immunotherapy and vaccine development. Our advanced technologies enable comprehensive B- and T-cell biomarker discovery, immune monitoring, and facilitate the clinical development of therapies aimed at treating a variety of diseases. From cancer to autoimmune disorders and infectious diseases, our peptides are paving the way for more targeted, effective immunotherapies and vaccines.
Our Unique Peptide-Based Technologies
JPT Peptide Technologies leverages a diverse range of proprietary technologies for peptide synthesis and design, allowing us to address specific immunotherapy needs. These include:
- Systematic B- and T-cell biomarker discovery: Our peptide libraries span the entire proteome, enabling the identification of critical biomarkers for effective immune monitoring.
- Epitope mapping and monitoring: We offer tools to monitor individual epitope patterns, which are critical for understanding immune response. Our approach also includes tracking epitope spreading, which provides insights into how immune responses evolve during therapy.
- Natural sequence diversity & post-translational modifications: Unlike other market approaches, our technologies account for natural sequence variation and post-translational modifications, providing a more accurate and personalized immune profile.
Our peptide technologies have been applied across numerous therapeutic areas:
- Cancer Immunotherapy: Our peptide-based solutions aid in the development of personalized cancer vaccines by identifying tumor-specific antigens. This allows for a targeted immune response, improving therapeutic outcomes in cancers like melanoma, breast cancer, and prostate cancer.
- Infectious Diseases: In combating viral and bacterial infections, peptides offer a way to enhance vaccine efficacy by focusing on immune system training. Our solutions have been involved in projects targeting HIV, influenza, and COVID-19, contributing to the development of more effective vaccines.
- Autoimmune Diseases & Allergy: In autoimmune diseases such as multiple sclerosis or rheumatoid arthritis, peptide-based immunotherapies can modulate immune activity to prevent it from attacking the body’s own tissues. We also provide solutions for monitoring allergen-specific immune responses, aiding in the development of vaccines for allergies.
Why Choose JPT Peptide Technologies for Immunotherapy & Vaccine Development?
- Comprehensive Immune Monitoring: Our tools provide a broad and detailed understanding of immune responses, crucial for the development of effective immunotherapies.
- Epitope Focus: Monitoring epitope patterns and addressing epitope spreading during treatment is unique to our approach and essential for understanding long-term immune response.
- Customization: We tailor our peptide solutions to meet the specific needs of your project, whether you're targeting infectious diseases, cancer, or autoimmune conditions.
What is Cellular Immunotherapy

Types of Cell & Immunotherapies
Tumor-Infiltrating Lymphocytes Therapy
CAR-T Cell Therapy
T Cell Receptor Therapy
Engineered T Cell Receptor Therapy
Cytokine-Induced Killer Cell Therapy
CAR-NK Therapy
Dendritic Cell Therapy
CAR-M Therapy
